AngioDynamics ROE 2010-2024 | ANGO
Current and historical return on equity (ROE) values for AngioDynamics (ANGO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| AngioDynamics ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-02-29 | $-0.19B | $0.22B | -53.86% |
| 2023-11-30 | $-0.01B | $0.40B | -3.24% |
| 2023-08-31 | $0.01B | $0.43B | 1.99% |
| 2023-05-31 | $-0.05B | $0.38B | -12.77% |
| 2023-02-28 | $-0.04B | $0.40B | -8.76% |
| 2022-11-30 | $-0.03B | $0.41B | -7.64% |
| 2022-08-31 | $-0.03B | $0.41B | -7.53% |
| 2022-05-31 | $-0.03B | $0.42B | -6.04% |
| 2022-02-28 | $-0.04B | $0.43B | -8.98% |
| 2021-11-30 | $-0.04B | $0.43B | -8.63% |
| 2021-08-31 | $-0.03B | $0.44B | -7.62% |
| 2021-05-31 | $-0.03B | $0.44B | -6.88% |
| 2021-02-28 | $-0.17B | $0.46B | -37.16% |
| 2020-11-30 | $-0.17B | $0.45B | -34.65% |
| 2020-08-31 | $-0.17B | $0.46B | -31.87% |
| 2020-05-31 | $-0.17B | $0.46B | -29.13% |
| 2020-02-29 | $0.05B | $0.61B | 7.99% |
| 2019-11-30 | $0.06B | $0.61B | 9.35% |
| 2019-08-31 | $0.06B | $0.61B | 10.46% |
| 2019-05-31 | $0.06B | $0.62B | 10.95% |
| 2019-02-28 | $0.01B | $0.55B | 0.91% |
| 2018-11-30 | $0.02B | $0.55B | 3.31% |
| 2018-08-31 | $0.02B | $0.55B | 2.98% |
| 2018-05-31 | $0.02B | $0.54B | 3.02% |
| 2018-02-28 | $0.00B | $0.54B | 0.19% |
| 2017-11-30 | $-0.01B | $0.52B | -1.92% |
| 2017-08-31 | $0.00B | $0.52B | 0.77% |
| 2017-05-31 | $0.01B | $0.52B | 0.96% |
| 2017-02-28 | $-0.03B | $0.53B | -4.82% |
| 2016-11-30 | $-0.03B | $0.52B | -5.16% |
| 2016-08-31 | $-0.04B | $0.51B | -7.74% |
| 2016-05-31 | $-0.04B | $0.51B | -7.99% |
| 2016-02-29 | $-0.00B | $0.55B | -0.18% |
| 2015-11-30 | $-0.01B | $0.55B | -1.10% |
| 2015-08-31 | $-0.01B | $0.55B | -0.92% |
| 2015-05-31 | $-0.00B | $0.55B | -0.74% |
| 2015-02-28 | $-0.01B | $0.54B | -0.92% |
| 2014-11-30 | $0.00B | $0.54B | 0.74% |
| 2014-08-31 | $0.00B | $0.54B | 0.56% |
| 2014-05-31 | $0.00B | $0.54B | 0.56% |
| 2014-02-28 | $0.00B | $0.54B | 0.75% |
| 2013-11-30 | $-0.00B | $0.53B | -0.38% |
| 2013-08-31 | $0.00B | $0.53B | 0.00% |
| 2013-05-31 | $-0.00B | $0.53B | -0.19% |
| 2013-02-28 | $-0.01B | $0.53B | -1.33% |
| 2012-11-30 | $-0.01B | $0.53B | -1.61% |
| 2012-08-31 | $-0.01B | $0.52B | -1.71% |
| 2012-05-31 | $-0.01B | $0.52B | -1.37% |
| 2012-02-29 | $0.00B | $0.41B | 0.00% |
| 2011-11-30 | $0.01B | $0.41B | 1.47% |
| 2011-08-31 | $0.01B | $0.41B | 1.73% |
| 2011-05-31 | $0.01B | $0.41B | 1.99% |
| 2011-02-28 | $0.01B | $0.41B | 3.27% |
| 2010-11-30 | $0.01B | $0.40B | 3.05% |
| 2010-08-31 | $0.01B | $0.40B | 3.09% |
| 2010-05-31 | $0.01B | $0.39B | 3.13% |
| 2010-02-28 | $0.01B | $0.39B | 2.90% |
| 2009-11-30 | $0.01B | $0.38B | 2.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.242B | $0.339B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.329B | 26.67 |
| Intuitive Surgical (ISRG) | United States | $133.752B | 80.57 |
| DexCom (DXCM) | United States | $53.067B | 88.74 |
| Edwards Lifesciences (EW) | United States | $52.819B | 34.96 |
| IQVIA Holdings (IQV) | United States | $43.310B | 25.69 |
| IDEXX Laboratories (IDXX) | United States | $41.012B | 49.04 |
| Alcon (ALC) | Switzerland | $39.823B | 29.37 |
| STERIS (STE) | Ireland | $20.355B | 24.09 |
| Waters (WAT) | United States | $18.582B | 26.66 |
| Hologic (HOLX) | United States | $18.119B | 20.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.651B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.605B | 15.56 |
| ShockWave Medical (SWAV) | United States | $12.286B | 84.89 |
| Sysmex ADR (SSMXY) | Japan | $10.120B | 31.74 |
| Teleflex (TFX) | United States | $9.944B | 15.61 |
| Penumbra (PEN) | United States | $7.961B | 98.42 |
| Masimo (MASI) | United States | $7.246B | 40.64 |
| Globus Medical (GMED) | United States | $6.941B | 22.00 |
| Glaukos (GKOS) | United States | $5.074B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.950B | 25.25 |
| LivaNova (LIVN) | United Kingdom | $2.969B | 19.58 |
| TransMedics (TMDX) | United States | $2.964B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.763B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.704B | 18.55 |
| Nihon Kohden (NHNKY) | Japan | $2.379B | 20.12 |
| Integra LifeSciences Holdings (IART) | United States | $2.309B | 9.48 |
| Tandem Diabetes Care (TNDM) | United States | $2.258B | 0.00 |
| Inari Medical (NARI) | United States | $2.151B | 371.10 |
| RxSight (RXST) | United States | $2.031B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.784B | 0.00 |
| Veracyte (VCYT) | United States | $1.489B | 0.00 |
| OPKO Health (OPK) | United States | $0.871B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.867B | 16.03 |
| Artivion (AORT) | United States | $0.856B | 98.95 |
| Paragon 28 (FNA) | United States | $0.833B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.729B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.692B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.627B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.575B | 19.53 |
| IRadimed (IRMD) | United States | $0.531B | 30.81 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Nevro (NVRO) | United States | $0.469B | 0.00 |
| NeuroPace (NPCE) | United States | $0.402B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.379B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.346B | 11.66 |
| CVRx (CVRX) | United States | $0.309B | 0.00 |
| AxoGen (AXGN) | United States | $0.305B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.279B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| Accuray (ARAY) | United States | $0.220B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.190B | 10.26 |
| Atossa Genetics (ATOS) | United States | $0.187B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.116B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.101B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.086B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.072B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 113.33 |
| Vasomedical (VASO) | United States | $0.054B | 9.73 |
| Vicarious Surgical (RBOT) | United States | $0.050B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.021B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |